Recent Tweets

Biosimilar availability may not be in its purview, but the @US_FDA is still thinking about ways to help the industry deal with the issue and support sector growth.

Read more: https://pink.pharmaintelligence.informa.com/PS143305/BsUFA-III-Reauthorization-Process-Begins-With-US-FDA-Considering-Staffing-Uptake-Issues

#biosimilars

Load More...